celiprolol has been researched along with Myocardial Infarction in 4 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, the effect of celiprolol (beta-1-antagonist with beta-2-agonistic activity) on hemodynamic and electrocardiographic parameters of patients with congestive heart failure due to ischemic (iCMP) and non-ischemic (niCMP) origin should be evaluated." | 5.09 | Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy. ( Hennersdorf, MG; Perings, C; Vester, EG, 1999) |
| "In a randomized trial the effect was studied of celiprolol, a cardioselective beta receptor blocker with strong intrinsic activity (ISA) on the incidence of ventricular arrhythmias in patients with acute myocardial infarction (AMI)." | 5.06 | [Celiprolol in acute myocardial infarct]. ( Kratzer, H; Kühn, P; Payrhuber, K, 1986) |
| "Celiprolol has no influence on the adenylyl cyclase activity of the dog heart." | 2.37 | [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol]. ( Pittner, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Minatoguchi, S | 1 |
| Arai, M | 1 |
| Wang, N | 1 |
| Lu, C | 1 |
| Narentuoya, B | 1 |
| Uno, Y | 1 |
| Misao, Y | 1 |
| Takemura, G | 1 |
| Fujiwara, T | 1 |
| Fujiwara, H | 1 |
| Hennersdorf, MG | 1 |
| Perings, C | 1 |
| Vester, EG | 1 |
| Pittner, H | 1 |
| Payrhuber, K | 1 |
| Kratzer, H | 1 |
| Kühn, P | 1 |
1 review available for celiprolol and Myocardial Infarction
| Article | Year |
|---|---|
[Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
Topics: Adrenergic beta-Antagonists; Animals; Asthma; Blood Coagulation; Bronchi; Bronchial Spasm; Calcium C | 1985 |
2 trials available for celiprolol and Myocardial Infarction
| Article | Year |
|---|---|
Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathies; Ca | 1999 |
[Celiprolol in acute myocardial infarct].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Celiprolol; Cr | 1986 |
1 other study available for celiprolol and Myocardial Infarction
| Article | Year |
|---|---|
Celiprolol, a selective beta1-blocker, reduces the infarct size through production of nitric oxide in a rabbit model of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Celiprolol; Disease Models, Animal; Dose-Respo | 2007 |